These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 11401736

  • 1. Beta-blockers to reduce mortality in patients with systolic dysfunction: a meta-analysis.
    Lee S, Spencer A.
    J Fam Pract; 2001 Jun; 50(6):499-504. PubMed ID: 11401736
    [Abstract] [Full Text] [Related]

  • 2. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A, Macdonald PS, Keogh AM, Kotlyar E, Mellemkjaer S, Coleman CF, Elsik M, Krum H, Hayward CS.
    J Am Coll Cardiol; 2010 Apr 27; 55(17):1780-7. PubMed ID: 20413026
    [Abstract] [Full Text] [Related]

  • 3. Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10-Year Cohort.
    Tang CH, Wang CC, Chen TH, Hong CY, Sue YM.
    J Am Heart Assoc; 2016 Jan 06; 5(1):. PubMed ID: 26738790
    [Abstract] [Full Text] [Related]

  • 4. Beta blockers and congestive heart failure.
    Movahed A.
    Am Fam Physician; 2000 Dec 01; 62(11):2402-4. PubMed ID: 11130228
    [No Abstract] [Full Text] [Related]

  • 5. Older adults with heart failure treated with carvedilol, bisoprolol, or metoprolol tartrate: risk of mortality.
    Perreault S, de Denus S, White M, White-Guay B, Bouvier M, Dorais M, Dubé MP, Rouleau JL, Tardif JC, Jenna S, Haibe-Kains B, Leduc R, Deblois D.
    Pharmacoepidemiol Drug Saf; 2017 Jan 01; 26(1):81-90. PubMed ID: 27859924
    [Abstract] [Full Text] [Related]

  • 6. Beta-blocker benefit according to severity of heart failure.
    Bouzamondo A, Hulot JS, Sanchez P, Lechat P.
    Eur J Heart Fail; 2003 Jun 01; 5(3):281-9. PubMed ID: 12798825
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol.
    Metra M, Nodari S, D'Aloia A, Muneretto C, Robertson AD, Bristow MR, Dei Cas L.
    J Am Coll Cardiol; 2002 Oct 02; 40(7):1248-58. PubMed ID: 12383572
    [Abstract] [Full Text] [Related]

  • 9. Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure.
    Fröhlich H, Torres L, Täger T, Schellberg D, Corletto A, Kazmi S, Goode K, Grundtvig M, Hole T, Katus HA, Cleland JGF, Atar D, Clark AL, Agewall S, Frankenstein L.
    Clin Res Cardiol; 2017 Sep 02; 106(9):711-721. PubMed ID: 28434020
    [Abstract] [Full Text] [Related]

  • 10. The large-scale placebo-controlled beta-blocker studies in systolic heart failure revisited: results from CIBIS-II, COPERNICUS and SENIORS-SHF compared with stratified subsets from MERIT-HF.
    Wikstrand J, Wedel H, Castagno D, McMurray JJ.
    J Intern Med; 2014 Feb 02; 275(2):134-43. PubMed ID: 24118421
    [Abstract] [Full Text] [Related]

  • 11. The impact of beta-blockade on mortality rates in patients with congestive heart failure.
    Goldstein S, Gottlieb SS.
    J Card Fail; 2000 Jun 02; 6(2 Suppl 1):15-24. PubMed ID: 10908094
    [Abstract] [Full Text] [Related]

  • 12. Meta-analysis of effect of beta-blocker therapy on mortality in patients with New York Heart Association class IV chronic congestive heart failure.
    Whorlow SL, Krum H.
    Am J Cardiol; 2000 Oct 15; 86(8):886-9. PubMed ID: 11024409
    [No Abstract] [Full Text] [Related]

  • 13. Beta-blockers in heart failure. The 'new wave' of clinical trials.
    Krum H.
    Drugs; 1999 Aug 15; 58(2):203-10. PubMed ID: 10473016
    [Abstract] [Full Text] [Related]

  • 14. Beta-blockers for chronic heart failure: surviving longer but feeling better?
    Bolger AP, Al-Nasser F.
    Int J Cardiol; 2003 Nov 15; 92(1):1-8. PubMed ID: 14602210
    [Abstract] [Full Text] [Related]

  • 15. Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial).
    Di Lenarda A, Remme WJ, Charlesworth A, Cleland JG, Lutiger B, Metra M, Komajda M, Torp-Pedersen C, Scherhag A, Swedberg K, Poole-Wilson PA, COMET investors.
    Eur J Heart Fail; 2005 Jun 15; 7(4):640-9. PubMed ID: 15921806
    [Abstract] [Full Text] [Related]

  • 16. Effects of beta-blockers for congestive heart failure in pediatric and congenital heart disease patients: a meta-analysis of published studies.
    Cho MJ, Lim RK, Jung Kwak M, Park KH, Kim HY, Kim YM, Lee HD.
    Minerva Cardioangiol; 2015 Dec 15; 63(6):495-505. PubMed ID: 25283168
    [Abstract] [Full Text] [Related]

  • 17. Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure--COMET.
    Torp-Pedersen C, Poole-Wilson PA, Swedberg K, Cleland JG, Di Lenarda A, Hanrath P, Komajda M, Lutiger B, Metra M, Remme WJ, Scherhag A, Skene A, COMET Investigators.
    Am Heart J; 2005 Feb 15; 149(2):370-6. PubMed ID: 15846279
    [Abstract] [Full Text] [Related]

  • 18. In heart failure, all beta-blockers are not necessarily equal.
    Tang WH, Militello M, Francis GS.
    Cleve Clin J Med; 2003 Dec 15; 70(12):1081-7. PubMed ID: 14686687
    [Abstract] [Full Text] [Related]

  • 19. Meta-analysis of carvedilol versus beta 1 selective beta-blockers (atenolol, bisoprolol, metoprolol, and nebivolol).
    DiNicolantonio JJ, Lavie CJ, Fares H, Menezes AR, O'Keefe JH.
    Am J Cardiol; 2013 Mar 01; 111(5):765-9. PubMed ID: 23290925
    [Abstract] [Full Text] [Related]

  • 20. β-blockers in stage B: a precursor of heart failure.
    Sarraf M, Francis GS.
    Heart Fail Clin; 2012 Apr 01; 8(2):237-45. PubMed ID: 22405663
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.